Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

ELI LILLY AND COMPANY

(LLY)
OverzichtKoersenGrafiekenNieuwsRatingenAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuwsAnalyse MarketScreener
Nieuws in andere talen op ELI LILLY AND COMPANY
20/10ELI LILLY AND : FCA And AKS Claim Founded On Free Pharmaceutical Product Education Dismiss..
19/10ELI LILLY : résultats encourageants dans le diabète de type 2
19/10ELI LILLY AND : Tirzepatide results published in The Lancet show superior A1C and body wei..
19/10Eli Lilly and Company Provides Tirzepatide Results
18/10ELI LILLY AND : Declares Q4 Dividend of $0.85 a Share, Payable Dec. 10 to Shareholders of ..
18/10ELI LILLY AND : Lilly Declares Fourth-Quarter 2021 Dividend
18/10Eli Lilly and Company Declares Dividend for the Fourth Quarter of 2021, Payable on Dece..
14/10ELI LILLY AND : Releases Updated Data From Phase 3 Breast Cancer Trial
14/10ELI LILLY AND : Lilly Announces Updated Verzenioģ (abemaciclib) Phase 3 monarchE Trial Dat..
14/10Eli Lilly and Company Announces Updated Verzenioģ (abemaciclib) Phase 3 monarchE Trial ..
13/10AGILENT TECHNOLOGIES : Eli Lilly Get FDA's OK for Assay to Identify Early Breast Cancer
13/10ELI LILLY : nouvelle indication de la FDA pour Verzenio
13/10ELI LILLY AND : Combination Therapy Receives FDA Approval as Adjuvant Treatment for Certai..
13/10ELI LILLY AND : FDA Approves Verzenioģ (abemaciclib) as the First and Only CDK4/6 Inhibito..
13/10FDA Approves Verzenioģ (abemaciclib) as the First and Only CDK4/6 Inhibitor for Certain..
13/10ELI LILLY : FDA Approves Verzenio in Some High-Risk Early Breast-Cancer Patients
13/10Hemogenyx Pharmaceuticals plc Announces CDX Licence Agreement
13/10Hemogenyx Signs Licensing Agreement With Eli Lilly for Antibody
12/10ELI LILLY AND : Lilly Confirms Date and Conference Call for Third-Quarter 2021 Financial R..
11/10AstraZeneca antibody cocktail study shows success treating COVID-19
07/10ELI LILLY AND : Loxo Oncology at Lilly Announces Details of Presentations at 2021 AACR-NCI..
07/10Loxo Oncology at Lilly Announces Details of Presentations at 2021 AACR-NCI-EORTC Virtua..
06/10GLAXOSMITHKLINE : COVID SCIENCE-Booster shot improves immune response of chemotherapy pati..
05/10ELI LILLY AND : Report Finds Eli Lilly Produced Recalled Emergency Diabetes Drug in Plant ..
05/10CIPLA : to Acquire Rights to Sell in India Two Diabetes Products of US-based Eli Lilly
05/10IpiNovyx Bio, Inc. announced that it has received $10 million in funding from Viva BioI..
01/10ELI LILLY : résultats encourageants dans la colite ulcéreuse
01/10ELI LILLY AND : At Week 104, 75% of Patients with Ulcerative Colitis Taking Mirikizumab Ma..
01/10Eli Lilly and Company Announces at Week 104, 75% of Patients with Ulcerative Colitis Ta..
01/10L'OMS veut améliorer l'accès aux traitements contre le diabète
30/09ELI LILLY AND : Incyte Say Olumiant Improved Hair Regrowth in Studies to Treat Alopecia Ar..
30/09ELI LILLY : les promesses de l'Olumiant dans l'alopécie
30/09ELI LILLY : résultats encourageants dans le diabète de type 2
30/09LILLY, INCYTE : Olumiant Superior to Placebo in Scalp Hair Regrowth as Early as 24 Weeks
30/09ELI LILLY AND : Lilly's tirzepatide led to greater improvements in liver fat content compa..
30/09Lilly's Tirzepatide Led to Greater Improvements in Liver Fat Content Compared to Insuli..
30/09ELI LILLY AND : Lilly's tirzepatide led to greater time in range compared to insulin deglu..
30/09Eli Lilly and Company's Announces Phase 3 Surpass-3 Clinical Trial
29/09Health Care Stocks Mixed Premarket Wednesday
29/09ELI LILLY AND : Gets FDA Approval for Expanded Use of Erbitux With Braftovi for Colorectal..
29/09IpiNovyx Bio, Inc. announced that it expects to receive funding
28/09FDA Expands Lilly's ERBITUX Label with Combination of BRAFTOVI (encorafenib) for the Tr..
28/09ELI LILLY AND : to Lower Insulin Lispro Injection Costs in US by 40%
28/09ELI LILLY : baisse de 40% du prix d'Insuline Lispro aux USA
28/09Lilly cuts price of Lispro insulin injection by 40%
28/09ELI LILLY AND : Lilly again reduces list price of Insulin Lispro Injection as latest chang..
28/09Lilly Cuts List Price of Insulin Lispro Injection
27/09ELI LILLY AND : New Data from Verzenioģ (abemaciclib) monarchE Study to Be Featured in ESM..
27/09ELI LILLY AND : Recalls Glucagon Lot Due to Faulty Vial
25/09Eli Lilly and Company Issues Voluntary Nationwide Recall of One Lot of GLUCAGONģ Emerge..
25/09ELI LILLY AND COMPANY :  Issues Voluntary Nationwide Recall of One Lot o..
23/09Lilly to Supply the EU and EEA with Up to 220,000 Doses of Bamlanivimab
23/09GenEdit Inc announced that it has received $26 million in funding from a group of inves..
22/09ELI LILLY : contrat avec l'Europe pour un traitement du Covid
22/09ELI LILLY AND : Sets Pricing Terms For $1.5 Billion Cash Tender Offer
22/09ELI LILLY AND : to Deliver 220,000 COVID-19 Antibody Cocktail Doses to EU
21/09ELI LILLY AND : Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.5 ..
21/09ELI LILLY AND : Lilly Signs Pact with European Commission to Supply Bamlanivimab and Etese..
21/09Eli Lilly Announces Joint Procurement Agreement with the European Commission
21/09EU-Kommission unterschreibt Vertrag für weiteres Covid-19-Medikament
21/09ELI LILLY AND : Signs Pact With EU Commission to Supply COVID-19 Monoclonal Antibody Treat..
21/09Eli Lilly in Procurement Deal With EC to Supply Covid-19 Treatment
21/09ELI LILLY AND : Reports $2 Billion Tender Offer Results
21/09ELI LILLY AND : Lilly Raises $2 Billion In Buyback Offer Of Outstanding Debt Securities
21/09ELI LILLY AND : Lilly Announces the Early Tender Results of Its Pending Cash Tender Offer ..
21/09Lilly Announces the Early Tender Results of Its Pending Cash Tender Offer for Up to $1...
21/09ELI LILLY AND : Obviousness Of Method Claim Requires Expectation Of Success For Recited Pu..
20/09Tact.ai Technologies, Inc. announced that it has received $33 million in funding from d..
17/09MÄRKTE USA/Leichter - Zwischen China-Sorgen und "Hexensabbat"
17/09MÄRKTE USA/Wall Street im Bann von China und "Hexensabbat"
17/09MÄRKTE USA/Wall Street am Verfalltag mit leichten Abgaben
17/09Health Care Stocks Mixed Premarket Friday
17/09MÄRKTE USA/Wall Street am Verfalltag vor leichten Verlusten
17/09ABCELLERA BIOLOGICS : Lilly Announce Expanded FDA Emergency Use Authorization for COVID-19..
17/09ELI LILLY : la FDA étend l'utilisation d'un traitement Covid
1  2  3  4  5  6  7  8  9  10Volgende
Volgende evenement op ELI LILLY AND COMPANY
26/10/21